Insider Trading Alert - ICUI, MFRM, EBAY, COL And GBX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 5, 2013, 166 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $50.32 to $1,887,935,195.16.

Highlighted Stocks Traded by Insiders:

ICU Medical (ICUI) - FREE Research Report

Kovalchik Michael T who is Director at ICU Medical sold 917 shares at $60.56 on Nov. 5, 2013. Following this transaction, the Director owned 3,784 shares meaning that the stake was reduced by 19.51% with the 917 share transaction.

The shares most recently traded at $60.94, up $0.38, or 0.63% since the insider transaction.

The average volume for ICU Medical has been 170,200 shares per day over the past 30 days. ICU Medical has a market cap of $904.4 million and is part of the health care sector and health services industry. Shares are up 0.74% year to date as of the close of trading on Tuesday.

ICU Medical, Inc. engages in the development, manufacture, and sale of medical devices used in infusion therapy, oncology, and critical care applications. The company has a P/E ratio of 23.5. Currently there are 2 analysts that rate ICU Medical a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ICUI - FREE

TheStreet Quant Ratings rates ICU Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full ICU Medical Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Mattress Firm (MFRM) - FREE Research Report

Fendrich Stephen G. who is Chief Strategy Officer at Mattress Firm sold 500 shares at $30.00 on Nov. 5, 2013. Following this transaction, the Chief Strategy Officer owned 230,235 shares meaning that the stake was reduced by 0.22% with the 500 share transaction.

The shares most recently traded at $32.09, up $2.09, or 6.51% since the insider transaction. Historical insider transactions for Mattress Firm go as follows:

  • 4-Week # shares sold: 833
  • 12-Week # shares sold: 8,588
  • 24-Week # shares sold: 1.3 million

The average volume for Mattress Firm has been 259,300 shares per day over the past 30 days. Mattress Firm has a market cap of $1.1 billion and is part of the consumer goods sector and consumer durables industry. Shares are up 28.58% year to date as of the close of trading on Tuesday.

Mattress Firm Holding Corp., through its subsidiaries, operates as a specialty retailer of mattresses, and related products and accessories in the United States. The company has a P/E ratio of 23.2. Currently there are 6 analysts that rate Mattress Firm a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MFRM - FREE

TheStreet Quant Ratings rates Mattress Firm as a hold. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income and robust revenue growth. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, generally higher debt management risk and disappointing return on equity. Get the full Mattress Firm Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

eBay (EBAY) - FREE Research Report

Marcus David who is President, PayPal at eBay sold 4,483 shares at $52.54 on Nov. 5, 2013. Following this transaction, the President, PayPal owned 6,970 shares meaning that the stake was reduced by 39.14% with the 4,483 share transaction.

The shares most recently traded at $53.46, up $0.92, or 1.72% since the insider transaction. Historical insider transactions for eBay go as follows:

  • 4-Week # shares sold: 29,163
  • 12-Week # shares sold: 33,163
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 39,163

The average volume for eBay has been 9.8 million shares per day over the past 30 days. eBay has a market cap of $66.5 billion and is part of the services sector and retail industry. Shares are up 0.73% year to date as of the close of trading on Tuesday.

eBay Inc. provides online platforms, tools, and services to help individuals and merchants in online and mobile commerce and payments in the United States and internationally. The company has a P/E ratio of 24.5. Currently there are 24 analysts that rate eBay a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EBAY - FREE

TheStreet Quant Ratings rates eBay as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, increase in stock price during the past year and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full eBay Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Rockwell Collins (COL) - FREE Research Report

Allen Patrick E who is Sr. VP and CFO at Rockwell Collins sold 6,000 shares at $70.38 on Nov. 5, 2013. Following this transaction, the Sr. VP and CFO owned 28,196 shares meaning that the stake was reduced by 17.55% with the 6,000 share transaction.

The shares most recently traded at $70.71, up $0.33, or 0.47% since the insider transaction. Historical insider transactions for Rockwell Collins go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 5,308
  • 24-Week # shares sold: 142,166

The average volume for Rockwell Collins has been 890,500 shares per day over the past 30 days. Shares are up 21.32% year to date as of the close of trading on Tuesday.

Rockwell Collins, Inc. designs, produces, and supports communications and aviation electronics for commercial and military customers worldwide. It operates in two segments, Government Systems and Commercial Systems. The stock currently has a dividend yield of 1.7%. The company has a P/E ratio of 15.4. Currently there are 5 analysts that rate Rockwell Collins a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on COL - FREE

TheStreet Quant Ratings rates Rockwell Collins as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Rockwell Collins Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Greenbrier Companies (GBX) - FREE Research Report

Centurion Alejandro who is Pres GMO CEO Gunderson at Greenbrier Companies sold 5,000 shares at $31.42 on Nov. 5, 2013. Following this transaction, the Pres GMO CEO Gunderson owned 47,291 shares meaning that the stake was reduced by 9.56% with the 5,000 share transaction.

Malik Maren C. who is Vice President Admin at Greenbrier Companies sold 2,500 shares at $30.82 on Nov. 5, 2013. Following this transaction, the Vice President Admin owned 13,930 shares meaning that the stake was reduced by 15.22% with the 2,500 share transaction.

Manning Anne who is VP Corporate Controller at Greenbrier Companies sold 2,500 shares at $30.80 on Nov. 5, 2013. Following this transaction, the VP Corporate Controller owned 18,642 shares meaning that the stake was reduced by 11.82% with the 2,500 share transaction.

The shares most recently traded at $30.99, up $0.19, or 0.61% since the insider transaction. Historical insider transactions for Greenbrier Companies go as follows:

  • 4-Week # shares sold: 9,932
  • 12-Week # shares sold: 10,367
  • 24-Week # shares sold: 15,878

The average volume for Greenbrier Companies has been 248,800 shares per day over the past 30 days. Greenbrier Companies has a market cap of $874.5 million and is part of the services sector and transportation industry. Shares are up 92.64% year to date as of the close of trading on Tuesday.

The Greenbrier Companies, Inc. engages in the design, manufacture, and marketing of railroad freight car equipment in North America and Europe. The stock currently has a dividend yield of 3.44%. Currently there are 9 analysts that rate Greenbrier Companies a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GBX - FREE

TheStreet Quant Ratings rates Greenbrier Companies as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Greenbrier Companies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit

These 5 Health Care Stocks Are Breaking Out This Christmas

These 5 Health Care Stocks Are Breaking Out This Christmas

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal

ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal